Additional file 1 of The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}

Xu, Mengzhuo; Zhang, Xin; Ye, Runyu; Liu, Xueting; Sun, Lirong; Jia, Shanshan; Zhang, Zhipeng; Li, Xinran; Wang, Ziqiong; Liao, Hang; Shi, Rufeng; Liu, Kai; Wang, Si; Meng, Qingtao; Chen, Xiaoping

doi:10.6084/m9.figshare.24655824.v1

13063_2023_7726_MOESM1_ESM.docx (26.45 kB)

Additional file 1 of The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}

journal contribution

posted on 2023-11-29, 04:42 authored by Mengzhuo Xu, Xin Zhang, Runyu Ye, Xueting Liu, Lirong Sun, Shanshan Jia, Zhipeng Zhang, Xinran Li, Ziqiong Wang, Hang Liao, Rufeng Shi, Kai Liu, Si Wang, Qingtao Meng, Xiaoping Chen

Additional file 1. Reporting checklist for protocol of a clinical trial.

Additional file 1 of The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}

Funding

Nanjing Chia Tai Tianqing Pharmaceutical Co. LTD

History

Usage metrics

Categories

Keywords

Licence

Exports